If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Renal Disease

The '30-20-10' Rule for Renal Care

, , January 22, 2010

Nephrologists propose critical action eGFR thresholds to guide management of kidney disease patients.
 

High, Low Calcium Can Hike Death Risk in CKD Patients

January 20, 2010

Although abnormal calcium levels have been linked to an increased chance of premature death in dialysis patients, new research indicates a similar risk for people in earlier stages of CKD.
 

Study Identifies Predictors of CKD in Stone Formers

January 15, 2010

Diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD among individuals who have had kidney stones, researchers reported in the American Journal of Kidney Diseases (2009; published online ahead of print).
 

Statin May Prevent Cardiovascular Disease in Kidney Disease Patients

January 15, 2010

Lovastatin may prevent development of cardiovascular disease (CVD) in CKD patients, according to study findings published in the American Journal of Kidney Diseases (2009; published online ahead of print).
 

Microalbuminuria, Copeptin Linked

January 15, 2010

Plasma copeptin, a marker of endogenous vasopressin levels, is associated with microalbuminuria, independent of age and other potential confounders, according to study findings published in Kidney International (2010;77:29-36).
 

Higher Hemoglobin Found Beneficial

December 17, 2009

After 36 months of follow-up, patients were 26% less likely to die or start dialysis, study finds.
 

Ferric Citrate Promising as a Phosphate Binder

December 17, 2009

A lower pill burden for patients may be possible, researcher says.
 

CKD, Anemia, Microalbuminuria Increase Death Risk

December 17, 2009

SAN DIEGO—Anemia, CKD, and microalbuminuria are each independently associated with an increased risk of all-cause mortality, regardless of the presence of cardiovascular disease (CVD).
 

Hepcidin Predicts Hemoglobin Response to Iron Loading

December 17, 2009

Researchers also show that administration of erythropoietin is followed by marked reductions in circulating hepcidin.
 

A Possible Reason for ESA Resistance

December 17, 2009

Investigators believe elevated levels of endogenous soluble erythropoietin receptors may have a role.
 

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions